Acta Oncologica

5.9k papers and 133.1k indexed citations i.

About

The 5.9k papers published in Acta Oncologica in the last decades have received a total of 133.1k indexed citations. Papers published in Acta Oncologica usually cover Oncology (2.5k papers), Pulmonary and Respiratory Medicine (2.0k papers) and Radiology, Nuclear Medicine and Imaging (1.1k papers) specifically the topics of Advanced Radiotherapy Techniques (837 papers), Breast Cancer Treatment Studies (417 papers) and Cancer survivorship and care (411 papers). The most active scholars publishing in Acta Oncologica are Jens Overgaard, Bengt Glimelius, Cai Grau, ­Eero Pukkala, Anders Brahme, B. Maciejewski, H. Rodney Withers, Jeremy M. G. Taylor, Ingmar Lax and Jack F. Fowler.

In The Last Decade

Fields of papers published in Acta Oncologica

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Acta Oncologica. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Acta Oncologica

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Acta Oncologica. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Acta Oncologica with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025